You are here

Trendlines associate company in talks to be sold for US$16m

Proposed sale will result in delisting of ETView from Tel Aviv bourse


CATALIST-listed Trendlines Group said on Friday that its 26.46 per cent-owned associated company ETView Medical could soon be acquired for US$16 million - in what would be the medical tech (medtech) incubator's first exit of a portfolio company since it listed on the Singapore